Catalysts for $SNY
11 tracked
Oct 30, 2026
earnings
Sanofi earnings
Sanofi
→
Jul 30, 2026
earnings
Sanofi earnings
Sanofi
→
Apr 29, 2026
pdufa
Sanofi — teplizumab (PDUFA)
teplizumab
→
Apr 27, 2026
phase 3 completion
Sanofi — meningococcal [serotypes A, C, W-135, Y] vaccine (MenQuadfi) (Phase III Trial Completion)
meningococcal [serotypes A, C, W-135, Y] vaccine (MenQuadfi)
→
Apr 23, 2026
earnings
Sanofi earnings
Sanofi
→
Mar 5, 2026
approval
XYZAL ALLERGY 24HR (LEVOCETIRIZINE DIHYDROCHLORIDE) — FDA approval
Sanofi
→
Jul 22, 2025
approval
XYZAL ALLERGY 24HR (LEVOCETIRIZINE DIHYDROCHLORIDE) — FDA approval
Sanofi
→
Oct 28, 2022
approval
XYZAL ALLERGY 24HR (LEVOCETIRIZINE DIHYDROCHLORIDE) — FDA approval
Sanofi
→
Jul 13, 2022
approval
XYZAL ALLERGY 24HR (LEVOCETIRIZINE DIHYDROCHLORIDE) — FDA approval
Sanofi
→
Nov 10, 2020
approval
XYZAL ALLERGY 24HR (LEVOCETIRIZINE DIHYDROCHLORIDE) — FDA approval
Sanofi
→
Jan 31, 2017
approval
XYZAL ALLERGY 24HR (LEVOCETIRIZINE DIHYDROCHLORIDE) — FDA approval
Sanofi
→